![David Dornan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Dornan
Chief Tech/Sci/R&D Officer at
WHITEHAWK THERAPEUTICS, INC.
Net worth: 1 917 $ as of 29/06/2025
Profile
David Dornan is Chief Scientific Officer at Whitehawk Therapeutics, Inc. since 2025.
Former roles include Chief Scientific Officer at Elevation Oncology, Inc. from 2022 to 2025, Senior Vice President-Research & Manufacturing at Bolt Biotherapeutics, Inc. from 2019 to 2022, and Director & Head-Oncology Research at Gilead Sciences, Inc. from 2012 to 2017.
Education includes a doctorate from the University Of Dundee and an undergraduate degree from the University of Strathclyde.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2025 | 5,223 ( 0.01% ) | 1 917 $ | 29/06/2025 |
David Dornan active positions
| Companies | Position | Start |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/02/2025 |
Former positions of David Dornan
| Companies | Position | End |
|---|---|---|
| ELEN ONCO | Chief Tech/Sci/R&D Officer | 16/02/2025 |
| BOLT BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 10/03/2022 |
| GILEAD SCIENCES, INC. | Director/Board Member | 31/10/2017 |
Training of David Dornan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Elevation Oncology, Inc.
 Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- David Dornan
